Sze, L.-P.; Ho, V.M.-K.; Fung, W.-K.; Law, K.-H.; Tu, Y.; So, Y.-H.; Chung, S.-F.; Wong, W.-L.; Liu, Z.; Shum, A.S.-W.;
et al. The Synergistic Effects of rhArg with Bcl-2 Inhibitors or Metformin Co-Treatment in Multiple Cancer Cell Models. Cells 2026, 15, 164.
https://doi.org/10.3390/cells15020164
AMA Style
Sze L-P, Ho VM-K, Fung W-K, Law K-H, Tu Y, So Y-H, Chung S-F, Wong W-L, Liu Z, Shum AS-W,
et al. The Synergistic Effects of rhArg with Bcl-2 Inhibitors or Metformin Co-Treatment in Multiple Cancer Cell Models. Cells. 2026; 15(2):164.
https://doi.org/10.3390/cells15020164
Chicago/Turabian Style
Sze, Lai-Pan, Vicky Mei-Ki Ho, Wing-Ki Fung, Kin-Ho Law, Yifan Tu, Yik-Hing So, Sai-Fung Chung, Wing-Leung Wong, Zhen Liu, Alisa Sau-Wun Shum,
and et al. 2026. "The Synergistic Effects of rhArg with Bcl-2 Inhibitors or Metformin Co-Treatment in Multiple Cancer Cell Models" Cells 15, no. 2: 164.
https://doi.org/10.3390/cells15020164
APA Style
Sze, L.-P., Ho, V. M.-K., Fung, W.-K., Law, K.-H., Tu, Y., So, Y.-H., Chung, S.-F., Wong, W.-L., Liu, Z., Shum, A. S.-W., Lee, L. M.-Y., & Leung, Y.-C.
(2026). The Synergistic Effects of rhArg with Bcl-2 Inhibitors or Metformin Co-Treatment in Multiple Cancer Cell Models. Cells, 15(2), 164.
https://doi.org/10.3390/cells15020164
